Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging
- 1 May 2008
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 108 (5), 989-998
- https://doi.org/10.3171/jns/2008/108/5/0989
Abstract
Many factors relating to the safety and efficacy of convection-enhanced delivery (CED) into intracranial tumors are poorly understood. To investigate these factors further and establish a more clinically relevant large animal model, with the potential to investigate CED in large, spontaneous tumors, the authors developed a magnetic resonance (MR) imaging–compatible system for CED of liposomal nanoparticles into the canine brain, incorporating real-time MR imaging. Additionally any possible toxicity of liposomes containing Gd and the chemotherapeutic agent irinotecan (CPT-11) was assessed following direct intraparenchymal delivery. Four healthy laboratory dogs were infused with liposomes containing Gd, rhodamine, or CPT-11. Convection-enhanced delivery was monitored in real time by sequential MR imaging, and the volumes of distribution were calculated from MR images and histological sections. Assessment of any toxicity was based on clinical and histopathological evaluation. Convection-enhanced delivery resulted in robust volumes of distribution in both gray and white matter, and real-time MR imaging allowed accurate calculation of volumes and pathways of distribution. Infusion variability was greatest in the gray matter, and was associated with leakage into ventricular or subarachnoid spaces. Complications were minimal and included mild transient proprioceptive deficits, focal hemorrhage in 1 dog, and focal, mild perivascular, nonsuppurative encephalitis in 1 dog. Convection-enhanced delivery of liposomal Gd/CPT-11 is associated with minimal adverse effects in a large animal model, and further assessment for use in clinical patients is warranted. Future studies investigating real-time monitored CED in spontaneous gliomas in canines are feasible and will provide a unique, clinically relevant large animal translational model for testing this and other therapeutic strategies.Keywords
This publication has 28 references indexed in Scilit:
- Expression of receptor tyrosine kinases VEGFR‐1 (FLT‐1), VEGFR‐2 (KDR), EGFR‐1, PDGFRa and c‐Met in canine primary brain tumoursVeterinary and Comparative Oncology, 2006
- Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine modelJournal of Neurosurgery, 2004
- Granular Cell Tumor of the Canine Central Nervous System: Two CasesVeterinary Pathology, 2001
- Liposomal cancer chemotherapy: current clinical applications and future prospectsExpert Opinion on Investigational Drugs, 2001
- Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; In Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using Pro-drug ApproachExperimental Neurology, 2000
- Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administrationBrain Research, 2000
- Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue—cannula sealing timeJournal of Neurosurgery, 1999
- Convection-enhanced delivery of macromolecules in the brain.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Analysis of Survival in a Retrospective Study of 86 Dogs with Brain TumorsJournal of Veterinary Internal Medicine, 1991
- Clinical Signs of Tumors Affecting the Rostral Cerebrum in 43 DogsJournal of Veterinary Internal Medicine, 1988